Hematopoietic Stem Cell Transplantation (HSCT) is an established chemotherapy medical treatment demonstrated to be effective to halt disease progression in neurologic autoimmune diseases such as Multiple Sclerosis (MS), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Transverse Myelitis (TM) and Neuromyelitis Optica (NMO), all of which are treated at Clínica Ruiz.
You will receive world class medical attention with an innovative method that is internationally recognized. Through an outpatient based treatment program designed to provide maximum patient treatment safety, patients receive the best world class medical care at Clínica Ruiz. In addition, lodging and ground transportation are included to enhance convenience and comfort during your treatment stay.
We are the largest center in the world conducting HSCT. Doctor Ruiz Argüelles and Doctor Gómez-Almaguer have performed more than 2500 HSCT procedures during more than 20 years for hematological and autoimmune diseases. On May 2015 our international program was started, over 460 patients have been treated for MS since. Our transplant related mortality for MS patients is 0.22%. Positive results have been found in over 78% of MS patients..
Patients with MS-Multiple Sclerosis (RRMS, SPMS or PPMS), CIDP Chronic Inflammatory Demyelinating Polyneuropathy, TM Transverse Myelitis or NMO Neuromyelitis Optica and with an EDSS (Expanded Disability Status Scale) score of 8 or below.